KA/EN
Register
Medicines reference
Search
Search
Product

Biocan Novel Pi/L4

Favourites

Canine parainfluenza virus + Leptospira icterohaemorrhagiae + Leptospira canicola + Leptospira grippotyphosa + Leptospira australis · Bioveta, a.s.

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Dog Dog 1 ml (1 ml)
Aseptically reconstitute and immediately inject the entire 1 ml dose SC. Give two doses 3-4 weeks apart from 6 weeks of age, then one dose annually. Vaccinate healthy dogs only. Vaccinated dogs may shed the live CPiV strain. Do not use with hypersensitivity to the adjuvant or excipients. Not recommended in pregnancy/lactation. Common transient swelling; rare GI or hypersensitivity reactions require prompt symptomatic treatment. Other medicines case by case; do not mix. Store 2-8 C, do not freeze, protect from light and use immediately after reconstitution.
 · two doses 3-4 weeks apart, then annually		 two doses 3-4 weeks apart, then annually Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ბიოკან ნოველ Pi/L4 - საინექციო სუსპენზიის მოსამზადებელი ლიოფილიზატი და სუსპენზია ძაღლებისათვის.
№ 128-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Biocan Novel Pi/L4, Suspension

lyophilisate and suspension, 1 ml dose for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.1/10
Very good
vetman assessment

Biocan Novel Pi/L4

lyophilisate and suspension, 1 ml dose for dogs
Assessed clinical scopeDog · Full dog label from 6 weeks: CPiV and four-serogroup leptospirosis immunisation, mainly as the annual non-core booster · Subcutaneous
Care settingRisk-based preventive vaccination of a healthy dog, usually the annual booster between three-yearly core doses
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 128-11 · Verified on 21 Oct 2026

A very good annual leptospirosis and parainfluenza booster with current four-serogroup coverage. Use it on exposure risk rather than as a substitute for core vaccination.

Regulatory and scientific credibility9.0/10

The exact presentation is registered in Georgia (128-11) and holds a decentralised EU authorisation (SK 97/004/DC/15-S) with a current detailed SPC.

Clinical efficacy7.5/10

Leptospirosis vaccination with four serogroups including Australis is well supported where exposure exists; parenteral CPiV reduces signs and shedding but gives only partial protection against the wider canine respiratory complex.

Safety and tolerability8.0/10

Benefit-risk is favourable in healthy dogs, with common transient swelling and rare gastrointestinal or hypersensitivity reactions; pregnancy and lactation use is not recommended.

Clinical practicality8.0/10

One 1 ml dose a year pairs simply with three-yearly Biocan Novel core vaccination; a new or lapsed dog needs two primary doses 3-4 weeks apart.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use with hypersensitivity to the adjuvant or an excipient. Vaccinate clinically healthy dogs only.
  • This vaccine contains no CDV, CAV, CPV or rabies antigen. It does not replace core vaccination.
  • Leptospiral protection is serogroup-specific and lasts one year: give it every year while exposure risk persists, and restart with two doses if the interval has lapsed.
  • Parenteral CPiV covers one agent of the canine infectious respiratory complex and does not prevent all kennel cough.
  • Safety in pregnancy and lactation is not established and use is not recommended.
  • Transient injection-site swelling is common; rare gastrointestinal or hypersensitivity reactions need observation and prompt treatment. Vaccinated dogs may shed the live CPiV strain.
  • Store at 2-8 C, do not freeze, protect from light and inject the whole reconstituted 1 ml immediately.
Assessment sources
  1. EU UPD SPC 20262026
  2. Georgia NFA register 20262026
  3. ACVIM leptospirosis consensus 20232023
  4. Leptospirosis vaccine meta-analysis2022
  5. WSAVA vaccination 20242024
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine parainfluenza virus3.1 log10 TCID50/dose Leptospira icterohaemorrhagiae51 GMT ALR/dose Leptospira canicola51 GMT ALR/dose Leptospira grippotyphosa40 GMT ALR/dose Leptospira australis51 GMT ALR/dose
Formulation Type
Suspension
Administration route
Subcutaneous
Manufacturer
Bioveta, a.s. · Czechia
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ბიოკან ნოველ Pi/L4 - საინექციო სუსპენზიის მოსამზადებელი ლიოფილიზატი და სუსპენზია ძაღლებისათვის.
№ 128-11
Verified on: 21 Oct 2026
 EU Yes, veterinary
№ SK 97/004/DC/15-S
Verified on: 23 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml (1 ml)
Aseptically reconstitute and immediately inject the entire 1 ml dose SC. Give two doses 3-4 weeks apart from 6 weeks of age, then one dose annually. Vaccinate healthy dogs only. Vaccinated dogs may shed the live CPiV strain. Do not use with hypersensitivity to the adjuvant or excipients. Not recommended in pregnancy/lactation. Common transient swelling; rare GI or hypersensitivity reactions require prompt symptomatic treatment. Other medicines case by case; do not mix. Store 2-8 C, do not freeze, protect from light and use immediately after reconstitution.
 Dog Any weight Subcutaneous two doses 3-4 weeks apart, then annually
EU UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Biocan Novel Pi/L4 - official product information
EU Union Product Database, 2026

Canine parainfluenza virus: No dose supported by a publicly verifiable source yet

Leptospira icterohaemorrhagiae: No dose supported by a publicly verifiable source yet

Leptospira canicola: No dose supported by a publicly verifiable source yet

Leptospira grippotyphosa: No dose supported by a publicly verifiable source yet

Leptospira australis: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (1 more) Hide additional products

Same product line 1

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗